Thyas Co. Ltd., a venture from Kyoto University, is developing cancer immunotherapy technologies based on creating induced pluripotent stem (iPS)…...
Please subscribe to read the full story.
Japan's leading chemical industry newspaper
Footer
© 2016–2022 The Chemical Daily Co. Ltd., Bonuterra Inc. All Rights Reserved.
